orgovyx, nubeqa, & early taxotere | 2021 treatments in review | mark scholz, md
Published 2 years ago • 16K plays • Length 9:12
Download video MP4
Download video MP3
Similar videos
-
4:57
orgovyx: new fda approved hormone therapy | 2020: the year in review | mark scholz, md
-
3:57
nubeqa (darolutamide), a hormone therapy | ask a prostate expert, mark scholz, md
-
12:08
new fda approval: darolutamide for hormone-sensitive disease | mark scholz, md | pcri
-
6:46
what is nubeqa for prostate cancer and how does it work? | ask a prostate expert, mark scholz, md
-
11:01
treatment for few metastases | oligo-metastases disease | mark scholz, md | pcri
-
8:44
finding an oncologist for advanced disease | scanning for metastases early | mark scholz, md | pcri
-
10:55
treating high-risk gleason 8: a modern approach | mark scholz, md | pcri
-
3:24
bipolar androgen therapy for advanced disease | mark scholz, md | pcri
-
7:54
how radiation affects the prostate | mark scholz, md
-
7:00
comparing the second generation hormone therapies | ask a prostate expert, mark scholz, md
-
9:27
remission and cure after relapse prostate cancer | mark scholz, md | pcri
-
3:02
is chemotherapy the last resort? | ask a prostate expert, mark scholz, md
-
9:00
relapsed prostate cancer: treatments, side effects, & imaging | mark scholz, md | pcri
-
4:31
taxotere vs. jevtana - chemotherapy for prostate cancer | ask a prostate expert, mark scholz, md
-
3:50
darolutamide (nubeqa) lupron for high risk prostate cancer | learn about clinical trials
-
1:36
fda approves bayer's nubeqa (darolutamide) for non-metastatic castration-resistant prostate cancer
-
7:16
tracking recurrent cancer | ask a prostate expert, mark scholz, md
-
13:52
metastatic #prostatecancer treatment case study | #markscholzmd #alexscholz #pcri
-
10:53
new study: hormone therapy & heart disease | diet & exercise | mark scholz, md | pcri
Clip.africa.com - Privacy-policy